Pharmaceutical Industry
Page 47 of 100
LeadershipNovartis CEO Has One New Breakthrough Drug in the Medicine Cabinet: But It Could Be Costly
By Susie GharibNovember 30, 2018

By Brittany ShootNovember 29, 2018

By Renae ReintsNovember 21, 2018

By Lucas LaursenNovember 20, 2018

By Kevin KelleherNovember 16, 2018

By Brittany ShootNovember 12, 2018

By Brittany ShootNovember 1, 2018

By Lucas LaursenOctober 31, 2018

By Lucas LaursenOctober 31, 2018

HealthThe FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record
By Sy MukherjeeOctober 24, 2018

By Sy MukherjeeOctober 18, 2018

HealthNovartis Is Paying $2.1 Billion for Endocyte, a Company That’s Developing a New Prostate Cancer Treatment
By David MeyerOctober 18, 2018

By Brittany ShootOctober 11, 2018
Most Popular




